
Keywords: Insulin; Insulin-like growth factor-1 (IGF1); IGF1 receptor; Insulin analogues; Endometrial cancerErk1/2, extracellular signal-regulated kinase; IGF1R, insulin-like growth factor-1 receptor; INSR, insulin receptor; PARP, poly-(ADP ribose) polymerase